ZFIN Image: Kwon et al., 2009, Fig. 2

Image

Figure Caption

Fig. 2 Loss of Bmp-antagonists impairs otic induction. A, D: Expression of chd at 7.5 hpf, dorsal view (A), and chd and foxi1 at 9 hpf, lateral view (D). The preotic domain of foxi1 is indicated (ot). B, E: Expression of fsta at 10 hpf, dorsal view (B) and fsta and pax8, lateral view (E). The preotic domains of pax8 is indicated (ot). C, F: Expression of cv2 at 10.5 hpf as shown in a whole-mount specimen, dorsal view (C) and in cross section (F). The plane of section (f) and preplacodal ectoderm (ppe) are indicated. G–I: Otic vesicle at 26 hpf in a wild-type control (D), chd/fsta double-morphant (E), and chd/fsta/cv2 triple-morphant (F). J–L: Dorsal views of cldna expression in otic cells at 27 hpf in an fgf8-/- mutant (J), fgf8-/- mutant injected with chd/fsta-MO (K), and fgf8-/- mutant injected with chd/fsta/cv2-MO (L). M–R: Dorsal views of pax8 expression in pre-otic cells at 11 hpf (boxed area) in a wild-type control (M), chd/fsta double-morphant (N), chd/fsta/cv2 triple-morphant (O), fgf8^-/- mutant (P), fgf8-/- mutant injected with chd/fsta-MO (Q), and fgf8-/- mutant injected with chd/fsta/cv2-MO (R). Anterior is to the top in all images except G–I in which anterior is to the left. Scale bar = 25 μm. S, schematic diagram of the fsta exon/intron structure, the fsta-MO2 target site (bar), primer-binding sites used for RT-PCR (P1, P2 arrows), and the results of RT-PCR confirming that fsta-MO2 injection severely reduces fsta transcript levels.

Figure Data

Expression / Labeling details

Phenotype details

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Dev. Dyn.